ES539500A0 - PROCEDURE FOR PREPARING A PHARMACEUTICAL LIQUID FORMULATION OF DOUBLE-COATED CONTROLLED RELEASE DOSAGE FORMS - Google Patents

PROCEDURE FOR PREPARING A PHARMACEUTICAL LIQUID FORMULATION OF DOUBLE-COATED CONTROLLED RELEASE DOSAGE FORMS

Info

Publication number
ES539500A0
ES539500A0 ES539500A ES539500A ES539500A0 ES 539500 A0 ES539500 A0 ES 539500A0 ES 539500 A ES539500 A ES 539500A ES 539500 A ES539500 A ES 539500A ES 539500 A0 ES539500 A0 ES 539500A0
Authority
ES
Spain
Prior art keywords
preparing
procedure
double
dosage forms
controlled release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES539500A
Other languages
Spanish (es)
Other versions
ES8605975A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Battelle Development Corp
Original Assignee
Battelle Development Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Battelle Development Corp filed Critical Battelle Development Corp
Publication of ES8605975A1 publication Critical patent/ES8605975A1/en
Publication of ES539500A0 publication Critical patent/ES539500A0/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
ES539500A 1984-01-13 1985-01-11 Controlled release liquid dosage formulations for pharmaceuticals. Expired ES8605975A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57046984A 1984-01-13 1984-01-13

Publications (2)

Publication Number Publication Date
ES8605975A1 ES8605975A1 (en) 1986-04-01
ES539500A0 true ES539500A0 (en) 1986-04-01

Family

ID=24279767

Family Applications (1)

Application Number Title Priority Date Filing Date
ES539500A Expired ES8605975A1 (en) 1984-01-13 1985-01-11 Controlled release liquid dosage formulations for pharmaceuticals.

Country Status (11)

Country Link
EP (1) EP0169236A1 (en)
JP (1) JPS61500910A (en)
AU (1) AU3835885A (en)
CA (1) CA1239347A (en)
ES (1) ES8605975A1 (en)
GR (1) GR850069B (en)
IL (1) IL74049A0 (en)
IT (1) IT1184309B (en)
NZ (1) NZ210785A (en)
WO (1) WO1985003000A1 (en)
ZA (1) ZA85239B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE109659T1 (en) * 1986-03-21 1994-08-15 Eurasiam Lab MEDICINAL COMPOSITIONS.
SE8605515D0 (en) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A LIQUID DOSAGE FORM FOR ORAL ADMINISTRATION OF A PHARMACEUTICALLY ACTIVE SUBSTANCE
FI77573C (en) * 1987-05-08 1989-04-10 Orion Yhtymae Oy New texture.
US5030454A (en) * 1987-10-26 1991-07-09 Alza Corporation Method for delivering drug in tiny pills in liquid carrier
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
IT1226940B (en) * 1988-09-16 1991-02-22 Recordati Chem Pharm THERAPEUTIC SYSTEM WITH CONTROLLED RELEASE FOR LIQUID PHARMACEUTICAL FORMULATIONS
US5296236A (en) * 1988-09-16 1994-03-22 Recordati S.A., Chemical And Pharmaceutical Company Controlled release therapeutic system for a liquid pharmaceutical formulations
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
EP0535937B2 (en) * 1991-10-01 2008-05-21 Takeda Chemical Industries, Ltd. Prolonged release microparticle preparation and production of the same
US5160742A (en) * 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
IL104093A (en) * 1991-12-31 1999-06-20 Abbott Lab Prolamine coatings for taste-masking orally administrable medicaments
AU4198793A (en) † 1992-07-24 1994-01-27 Takeda Chemical Industries Ltd. Microparticle preparation and production thereof
US5744164A (en) * 1994-12-16 1998-04-28 Nestec S.A. Sustained release microparticulate caffeine formulation
EP1165042B1 (en) 1999-04-06 2005-02-02 Ethypharm Drinkable ibuprofen pharmaceutical suspension
FR2791888B1 (en) * 1999-04-06 2004-10-08 Ethypharm Lab Prod Ethiques ORAL PHARMACEUTICAL SUSPENSION
FR2821745B1 (en) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques GRANULES AND GRANULES COATED WITH MASK TASTE
WO2004096175A2 (en) * 2003-04-30 2004-11-11 Ranbaxy Laboratories Limited Taste masked microcapsules and processes for their preparation
CA2959414C (en) 2014-09-05 2023-03-14 Symbiomix Therapeutics, Llc Secnidazole for use in the treatment of bacterial vaginosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2805977A (en) * 1955-01-04 1957-09-10 Smith Kline French Lab Sustained release pharmaceutical preparation
US3265629A (en) * 1958-12-22 1966-08-09 Ncr Co Coating by phase separation
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation

Also Published As

Publication number Publication date
CA1239347A (en) 1988-07-19
GR850069B (en) 1985-05-03
ES8605975A1 (en) 1986-04-01
IT1184309B (en) 1987-10-28
WO1985003000A1 (en) 1985-07-18
JPS61500910A (en) 1986-05-08
EP0169236A1 (en) 1986-01-29
ZA85239B (en) 1985-08-28
NZ210785A (en) 1987-11-27
IT8519086A0 (en) 1985-01-11
IL74049A0 (en) 1985-04-30
AU3835885A (en) 1985-07-30

Similar Documents

Publication Publication Date Title
ES539500A0 (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL LIQUID FORMULATION OF DOUBLE-COATED CONTROLLED RELEASE DOSAGE FORMS
IS1530B (en) Process for the preparation of novel pharmaceutical compositions with a moderate release of the active substance
EP0224146A3 (en) Pharmaceutical preparation for the controlled release of active ingredients
IT8026513A0 (en) PROCEDURE AND COMPOSITION FOR THE PREPARATION OF CONTROLLED LONG-ACTING PHARMACEUTICALS.
ES524892A0 (en) A PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL TABLET
NO863670L (en) PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION OF A HYDROPHOBIC MEDICINE.
DK164408C (en) GROWTH HORMON-RELEASING FACTOR RELATIONSHIPS, RELATIONSHIPS FOR USE AS A THERAPEUTIC, PROCEDURE FOR THE PREPARATION OF RELATIONSHIPS, PHARMACEUTICAL PREPARATIONS CONTAINING ANY EFFECTIVE SUMMARY OF ANY EFFECTIVE QUANTITY
DK155172C (en) PROCEDURE FOR THE PREPARATION OF LIPOSOMATIC PHARMACEUTICAL PREPARATIONS
ES555289A0 (en) PROCEDURE FOR PREPARING AN EFFERVESCENT COMPOSITION OF RAPID DISSOLUTION OF A THERAPEUTIC AGENT
NO854194L (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS CONTAINING ANTRACYCLING GYCOSIDES.
NO171344C (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS CONTAINING Tissue PLASMINOGEN ACTIVATOR
PT88225A (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL FORMULATIONS CONTAINING DI-HYDROPYRIDINES
NO862096L (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS CONTAINING Tissue PLASMINOGEN ACTIVATOR.
ES523536A0 (en) "A METHOD FOR PREPARING A PHARMACEUTICAL MIXTURE WITH CONTROLLED RELEASE OF ACTIVE SUBSTANCE"
IT1134115B (en) PROCEDURE FOR PREPARING MICRO CAPS CONTAINING ACTIVE COMPOUNDS FROM THE PHARMACEUTICAL POINT OF VIEW
MX14533A (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL COMPOUNDS
ES490453A0 (en) A PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION OF ANALGESIC QUINAZOLINONES
IT7868892A0 (en) PROCEDURE FOR THE PREPARATION OF MICROCAPS CONTAINING A PHARMACEUTICAL SUBSTANCE
PH16618A (en) 7beta-aminothiadiazolyl-acetamido-3-cepem-4-carboxylic acid compounds,pharmaceutical preparation containing such compounds and the use of the latter
GB2181053B (en) Pharmaceutical formulations with controlled release of the active substance
PT87079A (en) PROCESS FOR THE PREPARATION OF DOPAMINE-BETA-HYDROXYLASE INHIBITORS AND OF PHARMACEUTICAL COMPOUNDS CONTAINING THEM
CY1228A (en) Bronchospasmolytically active compounds,processes for their preparation,pharmaceutical preparations containing them and their medicinal use
DK164771C (en) PROCEDURE FOR THE PREPARATION OF A NATIONAL PHARMACEUTICAL PREPARATION CONTAINING ERGOT-CYCLIC PEPTIDAL KALOIDS
PT83456A (en) Process for the preparation of pharmaceutical compositions with controlled release of active substance
IT1141663B (en) PROCEDURE FOR THE PREPARATION OF MICRO CAPSULES